全文获取类型
收费全文 | 1246篇 |
免费 | 129篇 |
国内免费 | 28篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 65篇 |
妇产科学 | 19篇 |
基础医学 | 121篇 |
口腔科学 | 52篇 |
临床医学 | 152篇 |
内科学 | 254篇 |
皮肤病学 | 15篇 |
神经病学 | 28篇 |
特种医学 | 304篇 |
外科学 | 105篇 |
综合类 | 25篇 |
预防医学 | 54篇 |
眼科学 | 9篇 |
药学 | 68篇 |
肿瘤学 | 120篇 |
出版年
2021年 | 10篇 |
2020年 | 4篇 |
2019年 | 12篇 |
2018年 | 28篇 |
2017年 | 12篇 |
2016年 | 14篇 |
2015年 | 19篇 |
2014年 | 25篇 |
2013年 | 25篇 |
2012年 | 25篇 |
2011年 | 24篇 |
2010年 | 48篇 |
2009年 | 31篇 |
2008年 | 24篇 |
2007年 | 37篇 |
2006年 | 26篇 |
2005年 | 22篇 |
2004年 | 18篇 |
2003年 | 36篇 |
2002年 | 21篇 |
2001年 | 28篇 |
2000年 | 23篇 |
1999年 | 25篇 |
1998年 | 61篇 |
1997年 | 75篇 |
1996年 | 81篇 |
1995年 | 51篇 |
1994年 | 39篇 |
1993年 | 45篇 |
1992年 | 24篇 |
1991年 | 18篇 |
1990年 | 34篇 |
1989年 | 50篇 |
1988年 | 52篇 |
1987年 | 45篇 |
1986年 | 39篇 |
1985年 | 39篇 |
1984年 | 16篇 |
1983年 | 15篇 |
1982年 | 20篇 |
1981年 | 15篇 |
1980年 | 17篇 |
1979年 | 13篇 |
1978年 | 15篇 |
1977年 | 25篇 |
1976年 | 18篇 |
1975年 | 15篇 |
1974年 | 4篇 |
1973年 | 9篇 |
1966年 | 9篇 |
排序方式: 共有1403条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
5.
6.
7.
8.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
9.
目的 探索LDH实验检测细胞活力的可行性。方法 原代培养骨髓细胞和软骨细胞,用LDH实验测定上述两组细胞的活力,并与镜下活体观察到细胞的生长状况相比较。与目前比较成熟的测定细胞活力的MTS实验的测得的值相比较。结果 LDH实验对上述两组细胞的活力的测定结果与镜下活体观察到的结果相符合。与MTS实验的测得的结果经统计学处理无显著差异。结论 LDH实验可用于细胞活力的直接测定,而对活细胞的生存、繁殖无影响。 相似文献
10.
Cerebellar toxicity with high-dose cytosine arabinoside 总被引:1,自引:0,他引:1
R H Herzig J D Hines G P Herzig S N Wolff P A Cassileth H M Lazarus D J Adelstein R A Brown P F Coccia S Strandjord 《Journal of clinical oncology》1987,5(6):927-932
CNS dysfunction, especially impaired cerebellar function, is the dose-limiting toxicity associated with high-dose cytosine arabinoside, which precludes doses of greater than 48 g/m2. Four hundred eighteen patients between the ages of 2 and 74 years with leukemia or lymphoma received 36 to 48 g/m2 cytosine arabinoside either alone or with anthracycline antibiotics, 4'-(9-acridinylamino) methane sulfon-m-anisidine (m-AMSA), or total body irradiation. In only 35 of 418 patients (8%) did severe cerebellar toxicity develop; it was irreversible or fatal in four (1%) patients. The age of the patient was a critical factor in the incidence of severe cerebellar toxicity. Patients greater than 50 years old had a statistically significant greater incidence of cerebellar toxicity compared with younger patients (26/137, 19%, v 9/281, 3%; P less than .0005, chi 2). Neither the diagnosis, disease status, sex, nor the regimen altered the incidence of severe cerebellar toxicity (when corrected for age). A second course of high-dose cytosine arabinoside, administered to 62 patients, did not increase the incidence of severe cerebellar toxicity, which occurred in five (8%) of these patients. Two of the five patients had severe toxicity with the initial course. Of the 60 patients with no antecedent cerebellar dysfunction, three (5%) had severe toxicity with the second course: one of 41 patients were less than 50 years old; two of 19 patients were greater than or equal to 50 years. Since the occurrence of severe cerebellar dysfunction is greatly affected by age, reduced doses of high-dose cytosine arabinoside should be given to patients greater than 50 years old, and methods for reducing the cerebellar toxicity should be investigated in these patients. 相似文献